secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001493152-24-017748
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric issues 458K shares at $0.94 to waive equity line restriction; no proceeds
--------------------------------------------------------------------------------

- Issued 458,000 shares to institutional investors at $0.94 per share in registered direct offering.
- Offering is to permanently waive variable rate transaction limitation from December 2023 Inducement Letters.
- Company will not receive any net proceeds; waiver enables use of existing equity line of credit.
- Company restricted from issuing additional shares for 30 days or until 15 million shares trade.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315224017748/0001493152-24-017748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315224017748/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer